bacterial fatty acid synthase inhibitors (Merck & Co)

N/A

Report date: 2025/03/17 20:00:36
NME

Base Information

Drug Namebacterial fatty acid synthase inhibitors (Merck & Co)
Drug Alias NameFabH/FabF inhibitors (Merck & Co)platencinplatensimycin
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionFatty acid synthase inhibitors
TargetsFatty acid synthase
Therapy Area/IndicationsDiabetes MellitusBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A